Benralizumab (CAT#: Gly-006CL)

Benralizumab (INN) is a monoclonal antibody which is being developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Gene Expression
  • Datasheet
  • MSDS
  • COA
RNA Expression

Specifications

  • Type
  • Humanized (from mouse) Whole antibody
  • Protein chemical formula
  • C6492H10060N1724O2028S42
  • Protein average weight
  • 146.0 kg/mol
  • CAS number
  • 1044511-01-4
  • Class
  • Antiasthmatics; Monoclonal antibodies
  • Mechanism of action
  • Interleukin 5 receptor antagonists

References

  • Synonyms
  • MEDI-563 (BIW-8405); Anti-IL-5Rα Mab; Anti-IL5Ra monoclonal antibody; Anti-interleukin-5 receptor alpha monoclonal antibody; BIW-8405-IL-5R; KHK 4563;

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "IL5RA"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Humanized Antibody Products Rabbit Monoclonal Antibody Products ADCC Enhanced Antibody Products Fab Antibody Products ScFv Antibody Products ScFv-Fc Chimera Products Extracellular Vesicle (EV) Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for Gly-006CL. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare